Sympathetic hyperactivity in patients with hypertension: pathogenesis and treatment. Part I

by A. S. Safaryan, V. D. Sargsyan
Published 2020-12-01

The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2)

by A. S. Safaryan, V. S. Sargsyan, D. V. Nebieridze
Published 2020-07-01

The role of plant stanols in the primary prevention of hypercholesterolemia in patients with arterial hypertension

by A. S. Safaryan, T. V. Kamyshova, D. V. Nebieridze, V. D. Sargsyan
Published 2019-06-01

TREATMENT ADHERENCE AS AN ESSENTIAL ELEMENT OF CARDIOVASCULAR DISORDERS MANAGEMENT

by D. V. Nebieridze, T. V. Kamyshova, A. S. Safaryan, V. D. Sargsyan
Published 2017-12-01

BETA-ADRENOBLOCKER THERAPY IN ARTERIAL HYPERTENSION, METABOLIC DISTURBANCES, AND TYPE 2 DIABETES MELLITUS

by D. V. Nebieridze, R. G. Kulieva, V. D. Sargsyan, N. L. Vinnitskaya
Published 2009-08-01

Energy-shifting formulae yield reliable reaction and capture probabilities

by A. Diaz-Torres, G.G. Adamian, V.V. Sargsyan, N.V. Antonenko
Published 2014-12-01

Risk reclassification in patients first contacting a doctor with uncomplicated hypertension

by T. V. Kamyshova, A. A. Sarycheva, V. D. Sargsyan, A. S. Safaryan, D. V. Nebieridze
Published 2019-12-01

The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 1)

by A. S. Safaryan, V. S. Sargsyan, T. V. Kamyshova, N. M. Akhmedzhanov, D. V. Nebieridze, E. A. Poddubskaya
Published 2019-11-01